Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
5.20
+0.05 (0.97%)
Feb 3, 2026, 3:04 PM CST
SHE:000597 Revenue
Northeast Pharmaceutical Group had revenue of 1.63B CNY in the quarter ending September 30, 2025, a decrease of -17.28%. This brings the company's revenue in the last twelve months to 6.85B, down -14.12% year-over-year. In the year 2024, Northeast Pharmaceutical Group had annual revenue of 7.50B, down -8.98%.
Revenue (ttm)
6.85B
Revenue Growth
-14.12%
P/S Ratio
1.08
Revenue / Employee
1.15M
Employees
5,964
Market Cap
7.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.50B | -740.62M | -8.98% |
| Dec 31, 2023 | 8.24B | -565.77M | -6.42% |
| Jan 1, 2023 | 8.81B | 663.83M | 8.15% |
| Dec 31, 2021 | 8.15B | 760.76M | 10.30% |
| Dec 31, 2020 | 7.38B | -835.75M | -10.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cisen Pharmaceutical | 3.56B |
| Hunan Jiudian Pharmaceutical | 3.05B |
| Shandong Wit Dyne Health | 2.36B |
| Guangxi Wuzhou Zhongheng Group | 2.29B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Jiuzhitang | 1.94B |
| Hunan Er-Kang Pharmaceutical | 1.29B |
| Beijing Sun-Novo Pharmaceutical Research | 1.02B |